109 related articles for article (PubMed ID: 1308047)
21. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
22. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction.
de Dios I; Urunuela A; Manso M
J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172
[TBL] [Abstract][Full Text] [Related]
23. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis.
Nakano S; Tachibana I; Otsuki M
Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770
[TBL] [Abstract][Full Text] [Related]
24. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
[TBL] [Abstract][Full Text] [Related]
25. The liver ultrastructure in caerulein and taurocholate acute pancreatitis in the rats.
Andrzejewska A; Długosz JW; Jurkowska G
Rocz Akad Med Bialymst; 1998; 43():117-36. PubMed ID: 9972048
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice.
Makovec F; Bani M; Cereda R; Chistè R; Revel L; Rovati LC; Setnikar I; Rovati LA
Peptides; 1986; 7(6):1159-64. PubMed ID: 3104890
[TBL] [Abstract][Full Text] [Related]
27. The role of adenosine A2a receptors in experimental acute pancreatitis.
Celiński K; Prozorow-Król B; Korolczuk A; Słomka M; Korobowicz E; Biskup W; Madro A; Cichoz-Lach H; Czechowska G
Adv Med Sci; 2006; 51():105-10. PubMed ID: 17357287
[TBL] [Abstract][Full Text] [Related]
28. Influence of adenosine receptors on the development of caerulein-induced acute pancreatitis.
Szczerbiński M; Celiński K; Słomka M; Kasztelan-Szczerbińska B; Cichoz-Lach H
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):245-56. PubMed ID: 12898930
[TBL] [Abstract][Full Text] [Related]
29. Asperlicin, a nonpeptidal cholecystokinin receptor antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats.
Wisner JR; Renner IG
Pancreas; 1988; 3(2):174-9. PubMed ID: 2453874
[TBL] [Abstract][Full Text] [Related]
30. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
[TBL] [Abstract][Full Text] [Related]
31. Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats.
Otsuki M; Tani S; Okabayshi Y; Nakamura T; Fujii M; Fujisawa T; Baba S; Itoh H
Pancreas; 1989; 4(2):237-43. PubMed ID: 2474165
[TBL] [Abstract][Full Text] [Related]
32. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
Hirano T; Manabe T
Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
[TBL] [Abstract][Full Text] [Related]
33. Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusion in rats.
Tomita H; Miyasaka K; Jimi A; Mishima Y; Funakoshi A
Pancreas; 1994 Sep; 9(5):638-45. PubMed ID: 7809019
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.
Niederau C; Liddle RA; Ferrell LD; Grendell JH
J Clin Invest; 1986 Oct; 78(4):1056-63. PubMed ID: 2428840
[TBL] [Abstract][Full Text] [Related]
35. A controlled trial of glucagon in acute experimental pancreatitis in rats.
Dürr HK; Weihe W; Bode C; Bode JC
Z Gastroenterol; 1977 Dec; 15(12):728-33. PubMed ID: 602326
[TBL] [Abstract][Full Text] [Related]
36. Influence of the CCK-antagonist loxiglumide on bile-induced experimental pancreatitis.
Leonhardt U; Seidensticker F; Fussek M; Stöckmann F; Creutzfeldt W
Int J Pancreatol; 1991 Sep; 10(1):73-80. PubMed ID: 1757732
[TBL] [Abstract][Full Text] [Related]
37. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y
Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301
[TBL] [Abstract][Full Text] [Related]
38. Effect of procainhydrochloride on phospholipase A2 catalytic activity in sodium taurocholate-induced acute experimental pancreatitis in rats.
Kahl S; Mayer J; Schuette K; Peuravuori H; Pross M; Schulz HU; Nevalainen TJ; Malfertheiner P
Dig Dis; 2010; 28(2):373-8. PubMed ID: 20814215
[TBL] [Abstract][Full Text] [Related]
39. Experimental acute pancreatitis induced by excessive doses of caerulein in rats; protective and therapeutic effects of trypsin inhibitor urinastatin and CCK receptor antagonist CR1392.
Tani S
Kobe J Med Sci; 1988 Apr; 34(2):93-112. PubMed ID: 3216603
[No Abstract] [Full Text] [Related]
40. Role of endogenous cholecystokinin and cholecystokinin-A receptors in the development of acute pancreatitis in rats.
Tachibana I; Shirohara H; Czako L; Akiyama T; Nakano S; Watanabe N; Hirohata Y; Otsuki M
Pancreas; 1997 Mar; 14(2):113-21. PubMed ID: 9057182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
